Cargando…

Oncological and functional results of the surgical treatment of vertebral metastases in patients with multiple myeloma”

BACKGROUND: In nearly 30% of patients with myeloma, pathological fractures are found to occur in the spine. If the patients are not treated promptly and satisfactorily, the quality of their lives diminishes. Currently, the standard treatment for metastatic lesions of the spine is radiotherapy, but s...

Descripción completa

Detalles Bibliográficos
Autor principal: Guzik, Grzegorz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5568288/
https://www.ncbi.nlm.nih.gov/pubmed/28830484
http://dx.doi.org/10.1186/s12893-017-0288-9
_version_ 1783258829870333952
author Guzik, Grzegorz
author_facet Guzik, Grzegorz
author_sort Guzik, Grzegorz
collection PubMed
description BACKGROUND: In nearly 30% of patients with myeloma, pathological fractures are found to occur in the spine. If the patients are not treated promptly and satisfactorily, the quality of their lives diminishes. Currently, the standard treatment for metastatic lesions of the spine is radiotherapy, but surgical intervention is becoming more frequent. It is very important to quickly identify metastases and implement surgical treatment before any fracture/s occur. METHODS: Over the period of 2010–2014 in our department, a total of 129 patients were treated for metastatic spinal myeloma. 73 patients underwent vertebroplasty and 56 patients were operated on through various methods. Indications for the surgery, its course, technique and outcome were subsequently evaluated. The majority of patients (76%) admitted for treatment, exhibited vertebral fractures. Most lesions were multiplace and involved the vertebral bodies. In 42% of the patients, radiological examinations showed symptoms of compression of the nervous structures, while clinical signs were observed in only 16% of the patients. The functional status of the patients was assessed using the Karnofsky scale, while pain intensity was measured in a VAS score, before and after the surgery. The oncological results were assessed as a survival rate and local recurrence rate. RESULTS: The average follow-up was conducted within 31 months (min 18, max 48). The patients after vertebroplasty survived 42 months, and the patients after surgery 23 months. Local recurrence of the disease was observed in 12 patients. In 10 patients, among a group of 21 with paresis, their neurological conditions improved. The average results of both their VAS score and Karnofsky performance score in patients after surgery was seen to have improved. Only sporadic postoperative complications after vertebroplasty and surgery were reported. CONCLUSIONS: Early diagnosis of myeloma spine metastasis is essential to achieve the desired results of treatment. Vertebroplasty, as advised, should be performed as early as possible. Both the functional and oncological results after vertebroplasty are beneficial and the complication rates are low. Three relevant factors were found in our study: patient’s age over 65 years, initial diagnosis over 3 years and stage III of disease were related, significantly and statistically to survival.
format Online
Article
Text
id pubmed-5568288
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-55682882017-08-29 Oncological and functional results of the surgical treatment of vertebral metastases in patients with multiple myeloma” Guzik, Grzegorz BMC Surg Research Article BACKGROUND: In nearly 30% of patients with myeloma, pathological fractures are found to occur in the spine. If the patients are not treated promptly and satisfactorily, the quality of their lives diminishes. Currently, the standard treatment for metastatic lesions of the spine is radiotherapy, but surgical intervention is becoming more frequent. It is very important to quickly identify metastases and implement surgical treatment before any fracture/s occur. METHODS: Over the period of 2010–2014 in our department, a total of 129 patients were treated for metastatic spinal myeloma. 73 patients underwent vertebroplasty and 56 patients were operated on through various methods. Indications for the surgery, its course, technique and outcome were subsequently evaluated. The majority of patients (76%) admitted for treatment, exhibited vertebral fractures. Most lesions were multiplace and involved the vertebral bodies. In 42% of the patients, radiological examinations showed symptoms of compression of the nervous structures, while clinical signs were observed in only 16% of the patients. The functional status of the patients was assessed using the Karnofsky scale, while pain intensity was measured in a VAS score, before and after the surgery. The oncological results were assessed as a survival rate and local recurrence rate. RESULTS: The average follow-up was conducted within 31 months (min 18, max 48). The patients after vertebroplasty survived 42 months, and the patients after surgery 23 months. Local recurrence of the disease was observed in 12 patients. In 10 patients, among a group of 21 with paresis, their neurological conditions improved. The average results of both their VAS score and Karnofsky performance score in patients after surgery was seen to have improved. Only sporadic postoperative complications after vertebroplasty and surgery were reported. CONCLUSIONS: Early diagnosis of myeloma spine metastasis is essential to achieve the desired results of treatment. Vertebroplasty, as advised, should be performed as early as possible. Both the functional and oncological results after vertebroplasty are beneficial and the complication rates are low. Three relevant factors were found in our study: patient’s age over 65 years, initial diagnosis over 3 years and stage III of disease were related, significantly and statistically to survival. BioMed Central 2017-08-23 /pmc/articles/PMC5568288/ /pubmed/28830484 http://dx.doi.org/10.1186/s12893-017-0288-9 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Guzik, Grzegorz
Oncological and functional results of the surgical treatment of vertebral metastases in patients with multiple myeloma”
title Oncological and functional results of the surgical treatment of vertebral metastases in patients with multiple myeloma”
title_full Oncological and functional results of the surgical treatment of vertebral metastases in patients with multiple myeloma”
title_fullStr Oncological and functional results of the surgical treatment of vertebral metastases in patients with multiple myeloma”
title_full_unstemmed Oncological and functional results of the surgical treatment of vertebral metastases in patients with multiple myeloma”
title_short Oncological and functional results of the surgical treatment of vertebral metastases in patients with multiple myeloma”
title_sort oncological and functional results of the surgical treatment of vertebral metastases in patients with multiple myeloma”
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5568288/
https://www.ncbi.nlm.nih.gov/pubmed/28830484
http://dx.doi.org/10.1186/s12893-017-0288-9
work_keys_str_mv AT guzikgrzegorz oncologicalandfunctionalresultsofthesurgicaltreatmentofvertebralmetastasesinpatientswithmultiplemyeloma